The death domain of tumor necrosis factor receptor 1 is necessary but not sufficient for Golgi retention of the receptor and mediates receptor desensitization

被引:34
作者
Gaeta, ML
Johnson, DR
Kluger, MS
Pober, JS
机构
[1] Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Pathol, New Haven, CT 06510 USA
[2] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA
[3] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA
[4] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA
关键词
D O I
10.1038/labinvest.3780126
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
TNF signals are mediated through two different receptors, TNFR1 and TNFR2. In endothelial cells, TNFR1 is predominantly localized in the Golgi apparatus and TNFR2 on the plasma membrane. To investigate structural features responsible for the disparate localization, endothelial cells were transfected with epitope-tagged or green fluorescent protein-fused wild type and mutant receptor molecules. Wild type receptors recapitulated the distribution of endogenous receptors. Deletions of the entire TNFR1 intracellular domain or of the C-terminal death domain (TNFR1(-DD)) allowed expression of the receptor on the plasma membrane. However, addition of the death domain to the C-terminus of TNFR2 (TNFR2(+DD) did not lead to Golgi-retention of this chimeric receptor. Overexpressed TNFR1, TNFR2, and TNFR2(+DD) increased basal expression of a cotransfected NF-kappa B-dependent promotor-reporter gene. Overexpressed TNFR1(-DD) did not activate NF-KB but acted as a ligand-specific dominant negative inhibitor of TNF actions. Unexpectedly, TNF responses were also inhibited by overexpressed TNFR1 and TNFR2(+DD), but not TNFR2. We conclude that the death domain of TNFR1 is required for retention of TNFR1 in the Golgi apparatus but is not sufficient to direct Golgi retention of a TNFR2(+DD) chimera, and that overexpressed receptors that contain the death domain (TNFR1 and TNFR2(+DD)) spontaneously activate NF-kappa B while inhibiting TNF responses.
引用
收藏
页码:1185 / 1194
页数:10
相关论文
共 41 条
  • [1] A novel cytoplasmic domain of the p55 tumor necrosis factor receptor initiates the neutral sphingomyelinase pathway
    Adam, D
    Wiegmann, K
    AdamKlages, S
    Ruff, A
    Kronke, M
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (24) : 14617 - 14622
  • [2] The tumor necrosis factor ligand and receptor families
    Bazzoni, F
    Beutler, B
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (26) : 1717 - 1725
  • [3] Cell surface trafficking of Fas: A rapid mechanism of p53-mediated apoptosis
    Bennett, M
    Macdonald, K
    Chan, SW
    Luzio, JP
    Simari, R
    Weissberg, P
    [J]. SCIENCE, 1998, 282 (5387) : 290 - 293
  • [4] BENNETT M, 1998, SCIENCE, V284, P1431
  • [5] IDENTIFICATION OF AN INDUCIBLE ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE
    BEVILACQUA, MP
    POBER, JS
    MENDRICK, DL
    COTRAN, RS
    GIMBRONE, MA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (24) : 9238 - 9242
  • [6] SELF-ASSOCIATION OF THE DEATH DOMAINS OF THE P55 TUMOR-NECROSIS-FACTOR (TNF) RECEPTOR AND FAS/APO1 PROMPTS SIGNALING FOR TNF AND FAS/APO1 EFFECTS
    BOLDIN, MP
    METT, IL
    VARFOLOMEEV, EE
    CHUMAKOV, I
    SHEMERAVNI, Y
    CAMONIS, JH
    WALLACH, D
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (01) : 387 - 391
  • [7] BRADLEY JR, 1995, AM J PATHOL, V146, P27
  • [8] CYTOPLASMIC TRUNCATION OF THE P55 TUMOR-NECROSIS-FACTOR (TNF) RECEPTOR ABOLISHES SIGNALING, BUT NOT INDUCED SHEDDING OF THE RECEPTOR
    BRAKEBUSCH, C
    NOPHAR, Y
    KEMPER, O
    ENGELMANN, H
    WALLACH, D
    [J]. EMBO JOURNAL, 1992, 11 (03) : 943 - 950
  • [9] CARLOS TM, 1990, BLOOD, V76, P965
  • [10] Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95
    Chinnaiyan, AM
    ORourke, K
    Yu, GL
    Lyons, RH
    Garg, M
    Duan, DR
    Xing, L
    Gentz, R
    Ni, J
    Dixit, VM
    [J]. SCIENCE, 1996, 274 (5289) : 990 - 992